Financings in Brief: EndoSonics
This article was originally published in The Gray Sheet
EndoSonics: Pleasanton, California-based catheter and intravascular imaging system manufacturer files registration statement with the Securities and Exchange Commission for a secondary offering of 2.3 mil. shares of common stock. Stock in EndoSonics closed at 13-1/2 on Oct. 13, the day the offering was announced. Piper Jaffray and Volpe, Welty & Co. are lead underwriters, EndoSonics says, noting that underwriters have an overallotment option to buy 345,000 additional shares...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.